Page last updated: 2024-11-04

risedronic acid and Acidosis, Renal Tubular

risedronic acid has been researched along with Acidosis, Renal Tubular in 1 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Acidosis, Renal Tubular: A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.

Research Excerpts

ExcerptRelevanceReference
"By 24 months, renal tubular acidosis was improved and the bone density had normalized."1.39Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome. ( Hirata, S; Inokuchi, N; Mori, H; Okada, Y; Saito, K; Tanaka, Y; Yamamoto, S, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, S1
Okada, Y1
Mori, H1
Hirata, S1
Saito, K1
Inokuchi, N1
Tanaka, Y1

Other Studies

1 other study available for risedronic acid and Acidosis, Renal Tubular

ArticleYear
Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome.
    Modern rheumatology, 2013, Volume: 23, Issue:2

    Topics: Acidosis, Renal Tubular; Bone Density Conservation Agents; Drug Therapy, Combination; Etidronic Acid

2013